• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,237.99 -160.73
( -0.21%)
Global Indices
Nasdaq
49,543.85 -540.61
(-1.08%)
Dow Jones
7,428.26 -93.98
(-1.25%)
Hang Seng
61,141.50 -1,512.55
(-2.41%)
Nikkei 225
10,172.40 -200.53
(-1.93%)
Forex
USD-INR
95.71 0.07
(0.07%)
EUR-INR
111.93 -0.13
(-0.12%)
GBP-INR
129.01 -0.31
(-0.24%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Fermenta Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
506414
INE225B01021
136.8250387
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
FERMENTA
11.82
868.95
EPS(TTM)
Face Value()
Div & Yield %
24.98
5
0.84
 

Lupin consolidated net profit rises 89.04% in the March 2026 quarter
May 08,2026
Net profit of Lupin rose 89.04% to Rs 1460.34 crore in the quarter ended March 2026 as against Rs 772.52 crore during the previous quarter ended March 2025. Sales rose 32.90% to Rs 7391.91 crore in the quarter ended March 2026 as against Rs 5562.20 crore during the previous quarter ended March 2025.

For the full year,net profit rose 62.51% to Rs 5332.84 crore in the year ended March 2026 as against Rs 3281.62 crore during the previous year ended March 2025. Sales rose 23.86% to Rs 27487.54 crore in the year ended March 2026 as against Rs 22192.11 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales7391.915562.20 33 27487.5422192.11 24
OPM %33.6323.75 -32.0723.81 -
PBDT2506.131289.02 94 8805.965184.26 70
PBT2059.34895.84 130 7430.464015.00 85
NP1460.34772.52 89 5332.843281.62 63